Onconova Therapeutics, Inc. - Special Call Transcript
Good morning and welcome to Onconova Therapeutics conference call to discuss the top line INSPIRE pivotal Phase III data. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) And I would now like to turn the conference call over to Avi Oler, Senior Vice President of Corporate Development & General Counsel.
Thank you, operator. Good morning and welcome to Onconova's conference call to discuss the INSPIRE top line data. Earlier this morning, we issued a press release outlining the results. If you have not seen this press release, it is available on the Investor Relations page of our website at www.onconova.com.
On today's call, Dr. Steve Fruchtman, Onconova's President and CEO, will discuss the data and next steps with the company's pipeline. Following Steve's remarks, we will move to the Q&A portion of the call, which will
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |